Application note: Workflow for antibody aggregate and fragment analysis
Posted: 14 December 2022 | Merck | No comments yet
A complete SEC-UV workflow has been developed to enable quantitative analysis of antibody fragments and aggregates. In detail, it includes:
- Procedure for heat stressing of antibodies
- System suitability test utilising a gel filtration standard
- SEC-UV method for sample separation and analysis.
Related content from this organisation
- Moderna-Merck & Co cancer vaccine with Keytruda shows late-stage promise
- Raman-based PAT tool could advance continuous vaccine manufacturing
- Merck acquires JSR Life Sciences chromatography business
- MSD acquisition to accelerate first-in-class COPD drug
- Next drug patent cliff to challenge Big Pharma strategy
Related topics
Analytical techniques, Biopharmaceuticals, Formulation, Manufacturing, QA/QC, Research & Development (R&D)








